Data Foundry

Drug recalls 2013

PredniSONE Tablets — Class II drug recall D-133-2013

Terminated recall by West-ward Pharmaceutical Corp., reported 2013-01-30, distributed nationwide. Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusi

Recall numberD-133-2013
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmWest-ward Pharmaceutical Corp., Eatontown, NJ, United States
Recall initiated2012-12-05
Classified2013-01-18
Reported by FDA2013-01-30
Terminated2014-05-16
DistributedNationwide (US)
Quantity60,289 bottles
NDC00143-1477-01, 00143-1477-05, 00143-1477-10
Lot numbers01/15, 68382A, 68382B, 68578A, 68578B, 68579A, 68580A, 68581A, 68581B, 68582A, 68582B

Product

PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

Reason for recall

Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-133-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.